Back to Market返回行情

AVTR Avantor, Inc.

USHealthcare
$10.39-1.19%ClosedMarket Cap: $7.09B

As of 2026-07-10 16:00

Why AVTR matters now

Avantor, Inc. (AVTR) is a US stock in Healthcare. The latest InvestLog snapshot shows $10.39 with -1.19% on the session and $7.09B in market capitalization; recent performance reads 1-month +25.39% and YTD -16.40%.

The latest financial table shown here is Q1 2026, with revenue of $1.58B, net income of $43.3M, and EPS of $0.06. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 6.7%.

The latest indexable market news headline is "Here's Why You Should Hold Avantor Stock in Your Portfolio for Now" from Zacks Investment Research.

Additional event context on this page matters because analyst consensus is Hold with a median target of $10.00; recent insider activity includes LUCIER GREGORY T filing P-Purchase. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

PEG

P/B

1.16

P/S

1.00

EV/EBITDA

79.42

DCF Value

$27.28

FCF Yield

6.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

32.1%

Operating Margin

-4.3%

Net Margin

-8.4%

ROE

-9.6%

ROA

-4.7%

ROIC

-2.7%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$1.58B$43.3M$0.06
Q4 2025$1.66B$52.4M$0.08
FY 2025$6.55B$-530.2M$-0.78
Q3 2025$1.62B$-711.8M$-1.04

Analyst Ratings

Consensus

Hold

Target (Consensus)

$9.17

Target (Median)

$10.00

Target Range

$7.00 - $11.00

Strong Buy: 0Buy: 3Hold: 11Sell: 2Strong Sell: 1
CitigroupNeutral
2026-04-30
Evercore ISI GroupIn Line
2026-04-30
BarclaysUnderweight
2026-04-15
BarclaysUnderweight
2026-03-06
Wells FargoOverweight
2026-02-13

Trading Activity

Insider Trades

LUCIER GREGORY Tdirector
Buy2026-05-11
SUMME GREGORY Ldirector
Sell2026-05-11
SEVERINO MICHAELdirector
Sell2026-05-11
MEHRA SANJEEV Kdirector
Sell2026-05-11
Massaro Joseph Rdirector
Sell2026-05-11

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

Beta

0.96

Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.